AXON Real-World turns patient experiences and healthcare data into meaningful evidence that informs decisions and improves access.
We help clients build real-world evidence plans that respond to stakeholder needs and market access realities. By combining insight, evidence and strategy, we shape communication that supports better access to innovative therapies.
Global real-world evidence, HEOR and market access clients.
Real-world experience.
Therapy areas with specialist expertise.
We develop strategic real-world evidence generation plans, support real-world study design and implementation, and establish governance that gives research clarity and confidence.
We review and synthesise evidence through targeted and systematic literature reviews, gap analyses, competitor reviews and landscape assessments.
We translate real-world research into publications, data visualisation and formats tailored to the needs of specific stakeholders.
We use clinical data and real-world evidence to assess and demonstrate the holistic value of a therapy for patients, physicians and healthcare systems.
We develop value narratives and communication frameworks that make product or initiative value clear to a broad range of stakeholders.
We design engagement strategies that help stakeholders understand how to assess value in specific settings.
We create access strategies that engage the right stakeholders, shape the healthcare environment and support patient access.
We build bespoke internal training for market access teams, helping them understand payor beliefs and behaviours and engage with confidence.
We implement engagement strategies with policymakers and governmental bodies to help shape healthcare priorities and environments.
Your real-world needs are specific to your evidence, stakeholders and access context. Tell us what you are trying to achieve and we will help define the path forward.
Explore how we help clients use real-world evidence to demonstrate value and support access.
AXON helped senior market access executives understand the payor landscape and mindset, while supporting local teams with the soft skills needed for payor negotiation and stronger internal collaboration.
READ MORE ›Following successful Phase 2 results, AXON developed a strategy and tactical plan to address evidence gaps, grounded in stakeholder insight and a comprehensive review of existing real-world evidence.
READ MORE ›To support a label extension in multiple sclerosis, AXON developed a value story informed by landscape analysis and qualitative interviews across priority European markets.
READ MORE ›